Jay Venkatesan - Net Worth and Insider Trading
Jay Venkatesan Net Worth
The estimated net worth of Jay Venkatesan is at least $187 Million dollars as of 2024-11-10. Jay Venkatesan is the Director, 10% Owner of Alpine Immune Sciences Inc and owns about 2,856,309 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $186 Million. Jay Venkatesan is the See Remarks of Angion Biomedica Corp and owns about 189,195 shares of Angion Biomedica Corp (ANGN) stock worth over $2 Million. Jay Venkatesan is also the Director of Exicure Inc and owns about 4,334 shares of Exicure Inc (XCUR) stock worth over $11,919. Details can be seen in Jay Venkatesan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay Venkatesan has not made any transactions after 2022-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay Venkatesan
Jay Venkatesan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay Venkatesan owns 8 companies in total, including Exicure Inc (XCUR) , Alpine Immune Sciences Inc (ALPN) , and Iovance Biotherapeutics Inc (IOVA) among others .
Click here to see the complete history of Jay Venkatesan’s form 4 insider trades.
Insider Ownership Summary of Jay Venkatesan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCUR | Exicure Inc | 2019-08-02 | director |
| ALPN | Alpine Immune Sciences Inc | 2021-09-17 | director & President |
| IOVA | Iovance Biotherapeutics Inc | 2013-05-22 | 10 percent owner |
 | | 2014-12-16 | EVP and General Manager |
| | 2012-09-28 | 10 percent owner |
| | 2011-11-02 | 10 percent owner |
| | 2022-05-25 | director & See Remarks |
| | 2021-02-04 | director & See Remarks |
Jay Venkatesan Latest Holdings Summary
Jay Venkatesan currently owns a total of 3 stocks. Among these stocks, Jay Venkatesan owns 2,856,309 shares of Alpine Immune Sciences Inc (ALPN) as of September 17, 2021, with a value of $186 Million and a weighting of 98.98%. Jay Venkatesan owns 189,195 shares of Angion Biomedica Corp (ANGN) as of May 25, 2022, with a value of $2 Million and a weighting of 1.01%. Jay Venkatesan also owns 4,334 shares of Exicure Inc (XCUR) as of August 2, 2019, with a value of $11,919 and a weighting of 0.01%.
Latest Holdings of Jay Venkatesan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2021-09-17 | 2,856,309 | 64.97 | 185,574,396 |
| ANGN | Angion Biomedica Corp | 2022-05-25 | 189,195 | 10.00 | 1,891,950 |
| XCUR | Exicure Inc | 2019-08-02 | 4,334 | 2.75 | 11,919 |
Holding Weightings of Jay Venkatesan
Jay Venkatesan Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay Venkatesan has made a total of 1 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alpine Immune Sciences Inc is the sale of 400,000 shares on September 17, 2021, which brought Jay Venkatesan around $4 Million.
According to the SEC Form 4 filings, Jay Venkatesan has made a total of 8 transactions in Angion Biomedica Corp (ANGN) over the past 5 years, including 6 buys and 2 sells. The most-recent trade in Angion Biomedica Corp is the acquisition of 1,131 shares on May 25, 2022, which cost Jay Venkatesan around $14,141.
According to the SEC Form 4 filings, Jay Venkatesan has made a total of 0 transactions in Exicure Inc (XCUR) over the past 5 years. The most-recent trade in Exicure Inc is the acquisition of 1,667 shares on August 2, 2019, which cost Jay Venkatesan around $500,000.
Insider Trading History of Jay Venkatesan
- 1
Jay Venkatesan Trading Performance
GuruFocus tracks the stock performance after each of Jay Venkatesan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jay Venkatesan is -9.55%. GuruFocus also compares Jay Venkatesan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jay Venkatesan within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jay Venkatesan's insider trading performs compared to the benchmark.
Performance of Jay Venkatesan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.72 | | | | | |
| Relative Return to S&P 500(%) | 8.73 | | | | | |
Jay Venkatesan Ownership Network
Ownership Network List of Jay Venkatesan
Ownership Network Relation of Jay Venkatesan
Jay Venkatesan Owned Company Details
What does Exicure Inc do?
Who are the key executives at Exicure Inc?
Jay Venkatesan is the director of Exicure Inc. Other key executives at Exicure Inc include 10 percent owner Dgp Co., Ltd. , director & Chief Executive Officer & CFO Jung Sang Kim , and director & Chief Executive Officer & CFO Josh Miller .
Exicure Inc (XCUR) Insider Trades Summary
Over the past 18 months, Jay Venkatesan made no insider transaction in Exicure Inc (XCUR). Other recent insider transactions involving Exicure Inc (XCUR) include a net sale of 3,162,777 shares made by Dgp Co., Ltd. ,
In summary, during the past 3 months, insiders sold 0 shares of Exicure Inc (XCUR) in total and bought 237,223 shares, with a net purchase of 237,223 shares. During the past 18 months, 680,000 shares of Exicure Inc (XCUR) were sold and 237,223 shares were bought by its insiders, resulting in a net sale of 442,777 shares.
Exicure Inc (XCUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exicure Inc Insider Transactions
Jay Venkatesan Mailing Address
Above is the net worth, insider trading, and ownership report for Jay Venkatesan. You might contact Jay Venkatesan via mailing address: C/o Ayer Capital Management, Lp, 230 California St, Suite 600, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
